Advertisement

Topics

Synlogic Doses First Subject In Phase I Trial Of Novel Class Of Synthetic Biotic Medicines

20:00 EDT 18 Jun 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: Synlogic Doses First Subject In Phase I Trial Of Novel Class Of Synthetic Biotic Medicines

NEXT ARTICLE

More From BioPortfolio on "Synlogic Doses First Subject In Phase I Trial Of Novel Class Of Synthetic Biotic Medicines"

Advertisement
Quick Search
Advertisement
Advertisement